GENERATE - 次世代の婦人科外科手術 - 婦人科適応におけるロボット支援手術 (GENERATE)
GENERATE - 次世代の婦人科外科手術 - 婦人科適応症におけるロボット支援手術 - 前向き、非介入、多施設共同、市販後臨床研究
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.
調査の概要
詳細な説明
A prospective, non-interventional, multi-center, post market clinical study.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Petra Kremer
- 電話番号:+49 151 62679136
- メール:petra.kremer@intusurg.com
研究連絡先のバックアップ
- 名前:Peter Appenrodt
- 電話番号:+49 173 2043740
- メール:peter.appenrodt@intusurg.com
研究場所
-
-
-
Berlin、ドイツ、13353
- 積極的、募集していない
- Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
-
Bochum、ドイツ、44791
- 積極的、募集していない
- Augusta-Kranken-Anstalt Bochum
-
Coburg、ドイツ、96450
- 積極的、募集していない
- Sana Kliniken Coburg
-
Cologne、ドイツ、50935
- 終了しました
- St. Elisabeth-Krankenhaus Köln-Hohenlind
-
Essen、ドイツ、45147
- 積極的、募集していない
- Universitätsklinikum Essen
-
Frankfurt am Main、ドイツ、60431
- 積極的、募集していない
- Agaplesion Markus Krankenhaus Frankfurt am Main
-
Freiburg im Breisgau、ドイツ、79106
- 募集
- Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
-
コンタクト:
- Markus Hübner, Prof. Dr.
-
Greifswald、ドイツ、17475
- 募集
- Universitätsmedizin Greifswald
-
コンタクト:
- Zaher Alwafai, Dr.
- 電話番号:+49 3834 86 6500
- メール:zaher.alwafai@med.uni-greifswald.de
-
Höxter、ドイツ、37671
- 積極的、募集していない
- St. Ansgar Krankenhaus Höxter
-
Kiel、ドイツ、24105
- 積極的、募集していない
- Universitätsklinikum Kiel
-
Nuremberg、ドイツ、90419
- 積極的、募集していない
- Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
-
Schwerin、ドイツ、19055
- 積極的、募集していない
- Helios Kliniken Schwerin
-
Tübingen、ドイツ、72076
- 積極的、募集していない
- Universitätsklinikum Tübingen - Frauenklinik
-
-
Free and Hanseatic City of Hamburg
-
Hamburg、Free and Hanseatic City of Hamburg、ドイツ、22457
- 積極的、募集していない
- Albertinen Krankenhaus Hamburg
-
-
Hesse
-
Wiesbaden、Hesse、ドイツ、65189
- 積極的、募集していない
- St. Josefs-Hospital Wiesbaden
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients with gynecological disease that may be treated by surgical intervention.
説明
Key Inclusion Criteria:
- Woman with 18 years of age or older
- Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
- Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System
Key Exclusion Criteria:
- Life expectancy of less than 1 year
- Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
- Current participation in a clinical study, if not pre-approved by Intuitive
- Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
da Vinci Patients
Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery |
Robotic-assisted surgery (da Vinci) |
|
Epidemiological Data Audit
Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery |
Non-da Vinci Surgery |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Number of complications related to the surgery up to 30 days
時間枠:30 days
|
Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed. |
30 days
|
|
Describe the number of patient-reported outcomes up to 12 months
時間枠:12 months
|
Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication |
12 months
|
|
Characterize the treatment decision as reported by the treating physician
時間枠:30 days
|
Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed |
30 days
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Investigate the impact of patient characteristics on surgery
時間枠:30 days
|
Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage) |
30 days
|
|
Investigate the impact of patient characteristics on clinical outcome
時間枠:30 days
|
Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation) |
30 days
|
|
Investigate the impact of patient characteristics on complications
時間枠:30 days
|
Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery) |
30 days
|
|
Describe the impact from surgery to the patient's quality of life and function
時間枠:12 months
|
Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months) |
12 months
|
|
Describe the number of Intuitive instruments used per procedure and patient characteristics
時間枠:30 days
|
Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient |
30 days
|
|
Describe the number of disease recurrence and re-operation at final patient follow-up
時間枠:12 months
|
Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed |
12 months
|
|
Describe the number of conversion per procedure and patient characteristics
時間枠:30 days
|
Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed |
30 days
|
|
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
時間枠:30 days
|
Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
時間枠:30 days
|
Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on complications (number of events per surgeon)
時間枠:30 days
|
Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon |
30 days
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Ingolf Juhasz-Böss, Prof. Dr.、University Hospital Freiburg
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 114363C
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。